Cardiac Performance System Data Collection Study

Sponsor
Sensydia Corporation (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05866666
Collaborator
Orlando Health, Inc. (Other)
115
1
12.1
9.5

Study Details

Study Description

Brief Summary

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Condition or Disease Intervention/Treatment Phase
  • Device: Cardiac Performance System (NSR)

Detailed Description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Study Design

Study Type:
Observational
Anticipated Enrollment :
115 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Cardiac Performance System Data Collection Study
Anticipated Study Start Date :
May 30, 2023
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
May 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Cardiac Function Monitoring

Subjects scheduled for cardiac catheterization will undergo measurement with the Cardiac Performance System non-invasive device for a brief period before the catheterization procedure.

Device: Cardiac Performance System (NSR)
Participants will be asked to wear the Cardiac Performance System, a non-invasive sensor device on their upper abdomen. The Cardiac Performance System monitoring device will continuously monitor cardiac function.

Outcome Measures

Primary Outcome Measures

  1. Cardiac Performance System electronic data for Cardiac Output [10 minutes before cardiac catheterization procedure]

    Cardiac function metric measurement including Cardiac Output to report in L/m.

  2. Cardiac Performance System electronic data for Pulmonary Artery Pressure [10 minutes before cardiac catheterization procedure]

    Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg.

  3. Cardiac Performance System electronic data for Pulmonary Capillary Wedge Pressure [10 minutes before cardiac catheterization procedure]

    Cardiac function metric measurement including Pulmonary Capillary Wedge Pressure to report in mmHg.

  4. Pulmonary Artery Catheter electronic data for Cardiac Output [60 minutes during cardiac catheterization procedure]

    Cardiac function metric measurement including Cardiac Output to report in L/m.

  5. Pulmonary Artery Catheter electronic data for Pulmonary Artery Pressure [60 minutes during cardiac catheterization procedure]

    Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg.

  6. Pulmonary Artery Catheter electronic data for Pulmonary Capillary Wedge Pressure [60 minutes during cardiac catheterization procedure]

    Cardiac function metric measurement including Pulmonary Capillary Wedge Pressure to report in mmHg.

  7. Echocardiography electronic data for Ejection Fraction [15 minutes at a time prior to or after Pulmonary Artery Catheter procedure]

    Cardiac function measurement including left ventricle ejection fraction to report in percentage.

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Ability to provide written informed consent

  • 22 years of age or older

  • Referred for cardiac catheterization for reasons including heart failure, evaluation before transplant, pulmonary hypertension, shortness of breath, valvular disease, etc.

Exclusion Criteria:
  • Previous Heart Transplant

  • Presence of Left Ventricular Assist Device

  • Presence of a Holter monitor or any other electrical leads on the chest at the time of sensor placement

  • Surgical scars/wounds/bandages/ports at the site of sensor placement

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orlando Health Orlando Florida United States 32806

Sponsors and Collaborators

  • Sensydia Corporation
  • Orlando Health, Inc.

Investigators

  • Principal Investigator: Yahaira Ortiz-Gonzalez, MD, Orlando Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sensydia Corporation
ClinicalTrials.gov Identifier:
NCT05866666
Other Study ID Numbers:
  • CPS_ORLANDO
First Posted:
May 19, 2023
Last Update Posted:
May 19, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2023